Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-48221
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Acuant AcuFill SDK 竞争条件问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Acuant AcuFill SDK是美国Acuant公司的一种数据捕获技术。可以从文档中提取所有主要数据字段。 Acuant AcuFill SDK 存在安全漏洞,该漏洞源于多个 MSI 从标准用户可写目录中执行。通过竞争条件和 OpLock 操作,这些文件可以被标准用户覆盖。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2022-48221
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-48221
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2022-48221

No comments yet


Leave a comment